Expensify financials
$2.24+4.19%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $142.1M | $139.2M | $150.7M | $169.5M | $142.8M |
| Gross profit | $71.5M | $75.0M | $83.8M | $106.8M | $89.1M |
| Gross margin | 50.3% | 53.9% | 55.6% | 63.0% | 62.4% |
| Operating income | -$18.0M | -$820.0K | -$33.1M | -$15.2M | -$10.3M |
| Net income | -$21.4M | -$10.1M | -$41.5M | -$27.0M | -$13.6M |
| Net margin | −15.1% | −7.2% | −27.5% | −15.9% | −9.5% |
| Diluted EPS | $-0.23 | $-0.12 | $-0.50 | $-0.33 | $-0.36 |
| EBITDA | -$9.6M | $6.0M | -$28.0M | -$9.8M | -$5.1M |
| Operating cash flow | $20.1M | $23.9M | $1.6M | $32.9M | $5.5M |
| Free cash flow | $20.1M | $23.9M | $175.0K | $32.3M | $2.8M |
| Diluted shares | 92.3M | 87.4M | 82.5M | 80.8M | 38.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $63.1M | $48.8M | $47.5M | $103.8M | $98.4M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Total debt | $0.00 | $0.00 | $22.7M | $67.0M | $67.6M |
| Total assets | $186.0M | $173.7M | $176.8M | $210.2M | $183.2M |
| Total liabilities | $53.2M | $45.4M | $76.0M | $113.0M | $106.6M |
| Shareholders' equity | $132.7M | $128.2M | $100.7M | $97.2M | $76.6M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology